MBIO:NASDAQ
Mustang Bio Inc
$0.54
arrow_downward
-3.75%(-0.021) 1D
Sep 4, 12:38:23 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.55
High
$0.56
Low
$0.54
Mkt. cap
4.11M
Avg. vol.
26.97K
Volume
18.99K
52-wk high
$1.84
52-wk low
$0.52
EPS
-$0.46
Beta
2.05
Shares outstanding
6.73M
No. of employees
4
Open
$0.55
High
$0.56
Low
$0.54
Mkt. cap
4.11M
Avg. vol.
26.97K
Volume
18.99K
52-wk high
$1.84
52-wk low
$0.52
EPS
-$0.46
Beta
2.05
Shares outstanding
6.73M
No. of employees
4
News stories
From web sources and news partners
AD HOC NEWS
·
7 hours ago
Mustang Bio stock holds steady as investors watch pipeline and funding outlook
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com